• 1. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 2. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 3. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides

Comprehensive Analysis of Hippuryl-Phe-Arg-OH (CAS No. 73167-83-6): Properties, Applications, and Research Insights

The compound Hippuryl-Phe-Arg-OH (CAS No. 73167-83-6) is a tripeptide derivative widely recognized for its role in biochemical and pharmaceutical research. With the increasing demand for peptide-based therapeutics and diagnostic tools, this molecule has garnered significant attention due to its unique structural properties and functional versatility. Researchers and industry professionals frequently search for terms like "Hippuryl-Phe-Arg-OH synthesis", "CAS 73167-83-6 applications", and "peptide derivatives in drug discovery", reflecting its relevance in modern science.

Structurally, Hippuryl-Phe-Arg-OH consists of three amino acid residues: hippuric acid (Hippuryl), phenylalanine (Phe), and arginine (Arg). This configuration enables it to serve as a substrate for enzymes such as trypsin and thrombin, making it invaluable in enzymatic assays and proteomics studies. The presence of the Arg-OH terminus enhances its solubility in aqueous solutions, a critical factor for in vitro applications. Recent studies have also explored its potential in targeted drug delivery systems, aligning with the growing trend of precision medicine.

One of the most searched questions related to CAS 73167-83-6 is its stability under varying pH conditions. Experimental data indicate that Hippuryl-Phe-Arg-OH remains stable in neutral to slightly acidic environments, but may degrade in strongly alkaline solutions. This property is crucial for researchers designing enzyme-linked immunosorbent assays (ELISAs) or other diagnostic platforms. Additionally, its compatibility with HPLC purification methods has made it a preferred choice for quality control in peptide manufacturing.

In the context of green chemistry, Hippuryl-Phe-Arg-OH has been evaluated for its environmental impact. Unlike some synthetic peptides, it exhibits low toxicity in ecotoxicological studies, addressing the rising demand for sustainable biomaterials. This aligns with global initiatives to reduce hazardous waste in laboratories, a topic frequently discussed in forums like ResearchGate and PubMed.

The pharmaceutical industry has shown keen interest in Hippuryl-Phe-Arg-OH due to its potential as a protease inhibitor. With the surge in research on antiviral peptides post-COVID-19, this compound has been screened for activity against viral proteases. While results are preliminary, its modular structure allows for easy modification to enhance bioactivity—a strategy central to rational drug design.

From a commercial perspective, suppliers often highlight CAS 73167-83-6 under categories like "research-grade peptides" or "biochemical reagents". Pricing trends indicate steady demand, particularly from academic institutions and contract research organizations (CROs). Analytical certificates typically include data on purity (>95%), mass spectrometry validation, and residual solvent levels, ensuring compliance with Good Laboratory Practice (GLP) standards.

Future directions for Hippuryl-Phe-Arg-OH research may include its integration into nanocarrier systems for cancer therapy or as a biomarker in neurodegenerative diseases. As peptide therapeutics continue to dominate clinical pipelines (e.g., GLP-1 analogs for diabetes), understanding the physicochemical properties of such building blocks becomes paramount. For those exploring peptide conjugation techniques or solid-phase peptide synthesis (SPPS), this compound offers a robust model for optimization studies.

In summary, Hippuryl-Phe-Arg-OH (CAS No. 73167-83-6) exemplifies the intersection of chemistry, biology, and medicine. Its adaptability to diverse applications—from basic research to advanced therapeutics—positions it as a staple in life science laboratories. As search queries evolve to include terms like "peptide stability in biorepositories" or "high-throughput screening substrates", this compound will likely remain a focal point of scientific inquiry.

• 744-46-7(HIPPURYL-Arg)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)